GAP
(Gemcitabine Abraxane Pancreas) trial
A PHASE II RANDOMIZED TRIAL COMPARING A COMBINATION OF ABRAXANE AND GEMCITABINE VERSUS GEMCITABINE ALONE AS FIRST LINE TREATMENT IN LOCALLY ADVANCED UNRESECTABLE PANCREATIC CANCER
· Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer e A GISCAD phase II randomized trial
Scarica il file